GALA RENEE D — SEC Form 4 Insider Trading Activity
Summary
Updated Jul 16, 2026
GALA RENEE D has filed 3 SEC Form 4 filings across 2 companies in the last 90 days.
Profile
Renee D. Gala is a corporate executive known for her roles as Director and President & CEO at Jazz Pharmaceuticals plc, a biopharmaceutical company focused on treatments for sleeping disorders and oncology. She has also held significant positions at Dexcom Inc., contributing to the growth and strategic direction of both companies.
Role
President & CEO
Notability
50/100
Board memberships
Jazz Pharmaceuticals plc
Dexcom Inc
Awards & honors
Led Jazz Pharmaceuticals' acquisition of GW Pharmaceuticals
Renee D. Gala is a corporate executive known for her roles as Director and President & CEO at Jazz Pharmaceuticals plc, a biopharmaceutical company focused on treatments for sleeping disorders and oncology. She has also held significant positions at Dexcom Inc., contributing to the growth and strategic direction of both companies.…
How many SEC Form 4 filings has GALA RENEE D submitted recently?
3 primary Form 4 filings in the last 90 days, covering 2 companies.
Where can I see all of GALA RENEE D's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
